ArticleJCO precision oncology2020

BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies.

Ruitao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.